CRESY Q1 2026 Earnings Strong EPS Performance Despite Market Headwinds PENG Q1 2026 Earnings EPS Beats Estimates by 2065 Shares Surge Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress FRME Q1 2026 Earnings EPS Beats Estimates by Nearly 9 as Stock Edges Lower MP Materials Q1 2026 Earnings Strong Profit Beat Defies Expectations VLY Q1 2026 Earnings EPS Beat Driven by Solid Net Interest Margin Performance